nav
Antigen Express
is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs.
»
read more about us
5/18/2010
GENEREX BIOTECHNOLOGY ANNOUNCES PUBLICATION OF NOVEL IMMUNOTHERAPEUTIC CANCER VACCINE RESULTS IN PATIENTS WITH PROSTATE CANCER
3/2/2010
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology
1/19/2010
Generex Makes Podium Presentation of Vaccine Technology Platform with Cancer & Influenza Updates at PepTalk 2010
© 2004 Antigen Express | One Innovation Drive | Worcester, MA 01605
Phone: (508) 852-8783 | Fax: (508) 852 8653 |
admin@antigenexpress.com
Website designed by
NRG Networks
